However, clinical research increasingly recognized that patients with metabolic diseases frequently experience clusters of systemic complications, including heart failure (HF), chronic kidney disease (CKD), and fatty liver disease, that single-target drugs historically failed to address comprehensively
The JAMA Network Open study noted that income was significantly associated with discontinuation rates, with lower-income patients more likely to stop treatment
Stenius-Aarniala B, Poussa T, Kvarnstrm J, Grnlund EL, Ylikahri M, Mustajoki P
Notably, in addition to B16-OVA melanoma tumors, the anti-tumor effects of inulin were also confirmed in tumor models of MCA205 fibrosarcoma and MC38 colorectal cancer (CRC) cell lines, and such effects were associated with the response of Th1 cells (69)
Follow ups, refills, Primary Care